2 results
Approved WMOWill not start
Primary objective:- To assess the safety of concizumab given as multiple s.c. doses to subjects with haemophilia ASecondary objectives:- To assess pharmacokinetics of concizumab in subjects with haemophilia A after multiple s.c. doses- To assess…
Approved WMORecruiting
To investigate the possibility of using low dose peri-tumoral Magtrace® injection for a complete magnetic, radiation free, procedure for sentinel lymph node (SLN) detection and evaluation. This objective, can be sub-divided in the following…